Verrica Pharmaceuticals Correlations

VRCA Stock

USD 0.48 0.04 9.09%

The correlation of Verrica Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Verrica Pharmaceuticals Correlation With Market

Very good diversification

The correlation between Verrica Pharmaceuticals and DJI is -0.29 (i.e., Very good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Verrica Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Verrica Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

For information on how to trade Verrica Stock refer to our How to Trade Verrica Stock guide.

Moving together with Verrica Stock

0.74	A	Agilent Technologies	Pair Corr
0.69	ME	23Andme Holding	Pair Corr
0.81	DMAC	DiaMedica Therapeutics	Pair Corr
0.7	VANI	Vivani Medical	Pair Corr
0.79	DNLI	Denali Therapeutics	Pair Corr
0.69	DNTH	Dianthus Therapeutics	Pair Corr
0.76	VCEL	Vericel Corp Ord	Pair Corr
0.73	VCYT	Veracyte	Pair Corr
0.74	VERV	Verve Therapeutics	Pair Corr
0.66	VERA	Vera Therapeutics	Pair Corr
0.61	DRTS	Alpha Tau Medical	Pair Corr
0.73	CDIOW	Cardio Diagnostics	Pair Corr
0.63	VIGL	Vigil Neuroscience	Pair Corr
0.65	VKTX	Viking Therapeutics	Pair Corr
0.73	VRAX	Virax Biolabs Group	Pair Corr
0.71	VRDN	Viridian Therapeutics	Pair Corr
0.84	VRPX	Virpax Pharmaceuticals	Pair Corr
0.69	VTGN	VistaGen Therapeutics	Pair Corr
0.79	VTRS	Viatris Sell-off Trend	Pair Corr
0.77	VTYX	Ventyx Biosciences	Pair Corr

Moving against Verrica Stock

0.49	VRTX	Vertex Pharmaceuticals Sell-off Trend	Pair Corr
0.37	EDSA	Edesa Biotech	Pair Corr

Related Correlations Analysis

	LIAN	IVA	EWTX	VIGL	CNTB	ABOS	ETON	NUVB	ELDN	VRNA
LIAN		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	LIAN
IVA	0.0		-0.51	-0.2	-0.81	-0.86	-0.41	-0.85	-0.66	0.63	IVA
EWTX	0.0	-0.51		0.68	0.76	0.68	0.7	0.57	0.8	0.13	EWTX
VIGL	0.0	-0.2	0.68		0.44	0.32	0.72	0.25	0.78	0.41	VIGL
CNTB	0.0	-0.81	0.76	0.44		0.91	0.55	0.89	0.8	-0.38	CNTB
ABOS	0.0	-0.86	0.68	0.32	0.91		0.43	0.93	0.77	-0.53	ABOS
ETON	0.0	-0.41	0.7	0.72	0.55	0.43		0.33	0.81	0.2	ETON
NUVB	0.0	-0.85	0.57	0.25	0.89	0.93	0.33		0.68	-0.59	NUVB
ELDN	0.0	-0.66	0.8	0.78	0.8	0.77	0.81	0.68		-0.06	ELDN
VRNA	0.0	0.63	0.13	0.41	-0.38	-0.53	0.2	-0.59	-0.06		VRNA
	LIAN	IVA	EWTX	VIGL	CNTB	ABOS	ETON	NUVB	ELDN	VRNA

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

NUVB	+ 0.93	ABOS
ABOS	+ 0.91	CNTB
NUVB	+ 0.89	CNTB
ELDN	+ 0.81	ETON
ELDN	+ 0.8	EWTX
ELDN	+ 0.8	CNTB

High negative correlations

ABOS	- 0.86	IVA
NUVB	- 0.85	IVA
CNTB	- 0.81	IVA
ELDN	- 0.66	IVA
VRNA	- 0.59	NUVB
VRNA	- 0.53	ABOS

Risk-Adjusted Indicators

There is a big difference between Verrica Stock performing well and Verrica Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Verrica Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
LIAN	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
IVA	3.00	0.53	0.18	(0.94)	3.10	(3.50)	5.84	(4.73)	23.67
EWTX	3.61	(0.94)	0.00	(0.72)	0.00	0.00	5.32	(8.50)	31.92
VIGL	3.97	(0.19)	0.00	(0.26)	0.00	0.00	7.77	(9.09)	27.97
CNTB	3.51	(0.69)	0.00	(0.89)	0.00	0.00	7.32	(7.07)	26.71
ABOS	3.21	(0.84)	0.00	3.49	0.00	0.00	7.14	(7.56)	19.77
ETON	3.63	0.26	0.05	0.12	4.27	(3.91)	8.66	(5.73)	25.22
NUVB	3.25	(0.56)	0.00	(0.67)	0.00	0.00	7.83	(7.61)	29.59
ELDN	2.85	(0.47)	0.00	(0.39)	0.00	0.00	4.71	(5.28)	19.61
VRNA	3.10	0.38	0.10	0.30	3.60	(3.21)	6.90	(6.76)	16.22

Verrica Pharmaceuticals Corporate Management

Eugene Scavola	Executive Operations	Profile
Terence Kohler	Chief Officer	Profile
Dr MBA	Head Development	Profile
Christopher Hayes	Secretary, Officer	Profile
Joe Bonaccorso	Chief Commercial Officer	Profile
Gary MD	Chief Officer	Profile
David Zawitz	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC